Novavax acquires two manufacturing facilities
The main facility will be used for commercial-scale production of the company’s vaccines and is said to provide twice the cGMP production capacity of their current facility. Novavax
Evogene and ELEO have entered a scientific collaboration aimed at discovering and developing new oral small-molecule inhibitors targeting the Proprotein convertase subtilisin/kexin type 9 (PCSK9) pathway for hyperlipidemia and cardiovascular diseases.
The development of therapeutic will make use of Intrexon’s UltraVector platform and RheoSwitch Therapeutic System. Adeona will utilize Intrexon’s transgene engineering platform for the controlled, precise and continuous
Revlimid is used to treat patients with transfusion-dependent anemia due to low-or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. Patients with MDS develop severe
Amneal’s Acetonide oil line of products are generics equivalent alternatives to the Hill Dermaceuticals’ corticosteroids including DermOtic ear drops and Derma-Smoothe/FS body and scalp oils. Fluocinolone Acetonide ear